GL1X · GenesisL1 explorer

Research workbench

HIV integrase core domain (in) in complex with dimer-spanning ligand

Analyse HIV integrase core domain (in) in complex with dimer-spanning ligand in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6VKA
Type
protein
Length
284 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
F2WR39
Ligands
QZV, SO4, IOD
Pockets
5 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrase (EC 2.7.7.-)protein14148% helix, 22% strandF2WR39
BIntegrase (EC 2.7.7.-)protein14348% helix, 22% strandF2WR39

Ligands and binding sites

  • QZV · 2,2'-{ethane-1,2-diylbis[oxyethane-2,1-diylcarbamoyl-4, 1-phenyleneethyne-2,1-diyl(5-methyl-1-benzofuran-2,3-diyl)]}diacetic acid · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 10 copies · chains A, B
  • IOD · Iodide ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11770.620.8333SO4
21160.470.7918empty
3950.450.7917empty
41130.440.7721empty
5900.400.7722SO4

Interfaces

1 interface between chains.

  • A–B · 1511 Ų buried · 21 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (oxidation).

Compared structures

  • 6VKA · HIV Integrase Core domain (IN) in complex with dimer-spanning ligand · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.